Boehringer Ingelheim has launched a cat-specific presentation of Metacam Injection combined with a new indication which permits the company's existing oral suspension (0.5mg/ml meloxicam) to be used for up to four follow-on days.

The company says…

Boehringer Ingelheim has announced that its NSAID, Metacam 0.5 mg/ml oral suspension for cats, is now licensed for the alleviation of mild to moderate post-operative pain associated with soft tissue surgery in guinea pigs.

Metacam is the first NSAID to…